Composition
- Active ingredients
- CEFIXIME 500MG/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFIXIME 100MG/5ML · For suspensionANDA065129-001 · Discontinued
- CEFIXIME 200MG/5ML · For suspensionANDA065355-001 · Prescription
- CEFIXIME 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050621-002 · Discontinued
- CEFIXIME 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050621-001 · Discontinued
- CEFIXIME 400MG · TabletANDA065130-001 · Discontinued
- CEFIXIME 400MG · CapsuleNDA203195-001 · Prescription
- CEFIXIME 200MG · Tablet, chewableANDA065380-003 · Discontinued
- CEFIXIME 100MG · Tablet, chewableANDA065380-001 · Discontinued
- CEFIXIME 150MG · Tablet, chewableANDA065380-002 · Discontinued
- CEFIXIME 500MG/5ML · For suspensionThis page
- CEFIXIME 100MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For suspensionNDA050622-001 · Discontinued
Official product information
At a glance
- Brand name
- Suprax
- Active substance
- cefixime
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Lupin LTD
- Status
- Prescription
- FDA approval
- 20 Feb 2013
- Application
- NDA202091-001